State Street SPDR标普生技ETF XBI 深 沪
等待开盘 07-02 09:30:00 美东时间
156.55
-1.700
-1.07%
华盛通- 最 高159.00
- 今 开157.93
- 成交量 757.20万股
- 最 低 156.19
- 昨 收 158.25
- 总市值 1006.62万
- 52周最高 160.01
- 市盈率 静 --
- 换手率 11776.12%
- 52周最低 83.8187
- 委 比 -60.69%
- 总股本 6.43万
- 历史最高 174.017
- 量 比 0.65
- 振 幅 1.78%
- 历史最低 42.5447
- 每 手 1
- 风险率 17.98%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Apogee Stock Slides After Blackstone Financing Deal And Positive Drug Data
Apogee shares fell after announcing a $1.3 billion Blackstone financing deal alongside positive Phase 2 eczema drug results.
05-27 22:06
Moderna's Legal Hit Steals Spotlight From Strong Sales
MRNA revenue hits $389M, beating Wall Street estimates. Despite a Q1 loss, Moderna eyes 10% growth and new flu vaccine approvals in 2026.
05-01 22:44
Tech Leads, Dow Lags As Oil Holds Near $92: What's Moving Markets Wednesday?
U.S. stocks were mixed at midday Wednesday as tech stocks rallied while industrials dragged the Dow lower. Oil held above $90 and yields ticked higher, reflecting lingering geopolitical risk.
04-16 01:16
Citigroup, Morgan Stanley, CBRE Group And More On CNBC's 'Final Trades'
Experts predict higher stock prices for CBRE Group and Morgan Stanley, while State Street SPDR S&P Biotech ETF and Citigroup are recommended.
04-14 20:05
Neurocrine Buys Soleno To Tap High-Growth Rare Disease Market
Neurocrine (NBIX) to acquire Soleno Therapeutics (SLNO) for $2.9B to expand its rare disease portfolio. Get the deal details here.
04-06 20:13
BridgeBio Pharma Eyes First Treatment For Rare Muscle Disorder As Trial Data Shows Early Progress
BridgeBio Pharma shares Phase 3 trial update, but early data show progress for rare muscle disease treatment.
03-12 19:47
美股盘后 | VERTIV HOLDINGS LLC涨5.47%，Corebridge Financial, Inc.涨4.34%
VERTIV HOLDINGS LLC涨5.47%；Corebridge Financial, Inc.涨4.34%；回声星通信涨4.00%
03-07 07:11
FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars
Moderna's mRNA-1010 flu vaccine clears FDA review, with stock rising ahead of major approvals.
02-19 02:20
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak Proof
PTC Therapeutics, Inc. (PTCT) stock closed lower following the withdrawal of its New Drug Application for Translarna by the FDA.
02-13 19:18
Moderna, Mexico Partner To Boost Local Vaccine Production
Moderna signs a long-term deal with Mexico to build local mRNA production, transfer technology, and supply up to 10 million COVID vaccine doses for the 2025–2026 campaign.
02-11 01:26
